CLINICAL_TRIALS
trial_result
· 2009-05-25
Clinical Trial Update: A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate [Phase 3]
Summary
Phase 3 trial evaluating retreatment with rituximab in rheumatoid arthritis patients receiving background methotrexate; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2009-05-25